logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

DTC: low-dose RAI found sufficient in UK HiLo trial

Similar recurrence rate with low- vs high-dose RAI in low- and intermediate-risk patients.